There are very few people who have not been impacted by a cancer diagnosis, either personally or to someone they love. Lung cancer is often one of the most deadly, primarily because symptoms rarely appear until advanced stages. There is very little chance of detecting it in early stages.
But what if there was a blood test to measure metabolic signatures of immune cells responding to disease. Could this deadly form of cancer be accurately detected in Stage 1?
Israeli researchers think so! A pair of brothers, Giora and Eyal Davidovits, are focused on lung cancer today, but believe their immunometabolism approach will lead to breakthroughs in other autoimmune conditions as well.
Read more about their work here, and praise God for providing knowledge and wisdom to those who strive to make the world a better place!